Biological Products, (No Diagnostic Substances) · DE · CIK 1601830
Recursion decodes biology using an AI platform to discover and develop new medicines faster and better
Comparable business profile · signals at a glance
In the 90 days to Mar 23, 2026: 4 sold $3.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Gibson ChristopherDirector | Sell | 40,000 | $3.25 | $130K |
| Mar 17, 2026 | Taylor Ben RChief Financial Officer | Sell | 7,956 | $3.39 | $27K |
| Mar 9, 2026 | Khan NajatCEO and President | Sell | 28,298 | $3.35 | $95K |
| Mar 3, 2026 | Borgeson BlakeDirector | Sell | 170,000 | $3.46 | $588K |
| Feb 19, 2026 | Gibson ChristopherDirector | Sell | 40,000 | $3.46 | $138K |
| Feb 18, 2026 | Taylor Ben RChief Financial Officer | Sell | 13,426 | $3.08 | $41K |
| Feb 4, 2026 | Gibson ChristopherDirector | Sell | 40,000 | $4.12 | $165K |
| Feb 3, 2026 | Borgeson BlakeDirector | Sell | 220,000 | $4.20 | $924K |
| Jan 20, 2026 | Gibson ChristopherDirector | Sell | 40,000 | $4.47 | $179K |
| Jan 6, 2026 | Borgeson BlakeDirector | Sell | 220,000 | $4.36 | $959K |
| Jan 5, 2026 | Gibson ChristopherDirector | Sell | 40,000 | $4.25 | $170K |
| Dec 29, 2025 | Taylor Ben RChief Financial Officer | Sell | 21,383 | $4.18 | $89K |
| Dec 22, 2025 | Khan NajatChief R&D Commercial Officer | Sell | 124,403 | $4.41 | $549K |
| Dec 19, 2025 | Gibson ChristopherChief Executive Officer | Sell | 40,000 | $4.50 | $180K |
| Dec 4, 2025 | Gibson ChristopherChief Executive Officer | Sell | 40,000 | $4.63 | $185K |
| Dec 2, 2025 | Borgeson BlakeDirector | Sell | 220,000 | $4.37 | $961K |
| Nov 19, 2025 | Gibson ChristopherChief Executive Officer | Sell | 40,000 | $4.16 | $166K |
| Nov 4, 2025 | Gibson ChristopherChief Executive Officer | Sell | 40,000 | $5.21 | $208K |
| Oct 23, 2025 | Gibson ChristopherChief Executive Officer | Sell | 100,000 | $5.70 | $570K |
| Oct 10, 2025 | Gibson ChristopherChief Executive Officer | Sell | 100,000 | $6.04 | $604K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.